Estrella Immunopharma Inc.
ESLA | NASDAQ
$0.63
-$0.10 (-13.54%)
At close: Oct 30, 2026, 3:59 PM ET
$0.63
$0.00 (-0.65%)
Pre-market:
Nov 2, 2026, 4:00 AM ET
-13.54%
(1D)No price chart data available for 1D timeframe.
Rating
34.8
+3.0 ptsFundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #658/1028 (Top 64%)
Key Statistics
Market Data
Market Cap $27.23M
1D Range
0.63 0.74
52W Range
0.31 3.05
Valuation (TTM)
PE -2.52
PB -3.66
EV/EBITDA -2.77
Valuation (NTM)
Forward PE N/A
Forward PEG 0.04
Price Target $8.00
Cash Flow
FCF Yield -34.5%
SBC Adj. FCF Yield -36.1%
SBC Impact -4.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -7.6% |
-17.0%
FCF 3Y | 5Y 66.7% |
-22.1%
Returns
ROA -548.7%
ROE 121.7%
ROIC 131.8%
Financial Health
Net Cash
$146.67K
Current Ratio 0.20
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the ...
Sector Healthcare
Industry Biotechnology
Employees 3
IPO Date Sep 14, 2021
Website www.estrellabio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$8.00
Upside
+1169.84%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ESLA